Details for New Drug Application (NDA): 071480
✉ Email this page to a colleague
NDA 071480 describes NORETHIN 1/35E-21, which is a drug marketed by Watson Pharms Teva and is included in one NDA. Additional details are available on the NORETHIN 1/35E-21 profile page.
The generic ingredient in NORETHIN 1/35E-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
The generic ingredient in NORETHIN 1/35E-21 is ethinyl estradiol; norethindrone. There are twenty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the ethinyl estradiol; norethindrone profile page.
Summary for 071480
| Tradename: | NORETHIN 1/35E-21 |
| Applicant: | Watson Pharms Teva |
| Ingredient: | ethinyl estradiol; norethindrone |
| Patents: | 0 |
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL-21 | Strength | 0.035MG;1MG | ||||
| Approval Date: | Apr 12, 1988 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
